For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Nu Skin Enterprises, Inc (NYSE: NUS) closed the day trading at $5.48 down -2.32% from the previous closing price of $5.61. In other words, the price has decreased by -$2.32 from its previous closing price. On the day, 0.75 million shares were traded. NUS stock price reached its highest trading level at $5.725 during the session, while it also had its lowest trading level at $5.35.
Ratios:
For a better understanding of NUS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.86. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 31, 2023, Downgraded its rating to Hold and sets its target price to $39 from $43 previously.
BofA Securities Upgraded its Underperform to Neutral on October 02, 2020, whereas the target price for the stock was revised from $54 to $58.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 21 ’25 when Battle Emma S. sold 1,693 shares for $7.73 per share. The transaction valued at 13,087 led to the insider holds 17,530 shares of the business.
Battle Emma S. bought 1,693 shares of NUS for $13,087 on Feb 21 ’25. On May 28 ’24, another insider, LIPMAN ANDREW D, who serves as the Director of the company, sold 2,000 shares for $13.33 each. As a result, the insider received 26,660 and left with 23,225 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUS now has a Market Capitalization of 270762432 and an Enterprise Value of 544043840. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.16 while its Price-to-Book (P/B) ratio in mrq is 0.42. Its current Enterprise Value per Revenue stands at 0.314 whereas that against EBITDA is 3.413.
Stock Price History:
The Beta on a monthly basis for NUS is 0.97, which has changed by -0.5664557 over the last 52 weeks, in comparison to a change of 0.05430484 over the same period for the S&P500. Over the past 52 weeks, NUS has reached a high of $14.00, while it has fallen to a 52-week low of $5.60. The 50-Day Moving Average of the stock is -24.00%, while the 200-Day Moving Average is calculated to be -29.09%.
Shares Statistics:
Over the past 3-months, NUS traded about 711.52K shares per day on average, while over the past 10 days, NUS traded about 817730 shares per day. A total of 49.80M shares are outstanding, with a floating share count of 47.56M. Insiders hold about 3.73% of the company’s shares, while institutions hold 76.42% stake in the company. Shares short for NUS as of 1743379200 were 2320634 with a Short Ratio of 3.26, compared to 1740700800 on 2185997. Therefore, it implies a Short% of Shares Outstanding of 2320634 and a Short% of Float of 6.7299999999999995.
Dividends & Splits
NUS’s forward annual dividend rate is 0.24, up from 0.24 a year ago. Against a Trailing Annual Dividend Yield of 0.042780746The stock’s 5-year Average Dividend Yield is 4.68.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $1.2 and $0.9 for the fiscal current year, implying an average EPS of $1.04.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for NUS’s current fiscal year. The highest revenue estimate was $1.83B, while the lowest revenue estimate was $1.69B, resulting in an average revenue estimate of $1.76B. In the same quarter a year ago, actual revenue was $1.73B
